The Tartus Agriculture Directorate has intensified its inspection tours of veterinary drug manufacturing facilities, aiming to catch violations and ensure compliance with the technical and health requirements governing the handling of pharmaceutical products, in order to protect animal health and the safety of animal products.
Tartus Agriculture Director Mohammad Adnan Ahmad told a SANA reporter today, Thursday, that the violations detected during the tours included the absence of the Veterinarians' Syndicate label, the failure to write down the production and expiry dates, as well as the lack of a product identification label in some cases.
Operating Requirements for Warehouses and Factories
Ahmad explained that the operation of veterinary drug warehouses and factories requires technical supervision by a veterinarian, clean and suitable places for storage and manufacturing, and compliance with storage conditions, including providing cooling shelves and product identification labels.
He noted that haphazard handling of veterinary drugs and disregard for dosages and for the type and properties of the drug may affect animal health and safety, and may in turn affect the safety of animal products because of drug residues in them.
Legal Measures
He affirmed that the judicial police committees take legal action against violating facilities by confiscating the violating drugs, drawing up the necessary reports and referring them to the judiciary, noting that the tours cover warehouses, veterinary clinics, service offices and all other entities whose work involves veterinary drugs.
Context of the Tours
These tours come as part of efforts to regulate the veterinary drug and vaccine market in Syria and to strengthen oversight of their quality and the safety of their handling.
The Veterinarians' Syndicate affixes its label to imported vaccines in accordance with procedure, which helps distinguish authorized products and limit the entry of illegal or unknown-source products into the markets.
Source: Syrian Arab News Agency (SANA)

Comments (0)